Recent Articles from Business Wire

Axelspace Corporation (“Axelspace”), a leading microsatellite company committed to making “Space within Your Reach,” is pleased to announce a multi-launch agreement (MLA) with Exolaunch, a global launch integrator and leader in launch mission management, satellite integration and satellite deployment technologies.

Axelspace Corporation (“Axelspace”), a leading microsatellite company committed to making “Space within Your Reach,” has entered into a service agreement with Pale Blue Inc. (“Pale Blue”), a company that develops, manufactures, and sells thrusters (engines) for small satellites, for an in-orbit demonstration, as detailed below.

From Lily Allen creating the ultimate diss album, Lewis Capaldi beating Drake and Kendrick, to Katy Perry’s space adventure impacting her ticket sales - a new report unlocks fans favourite moments in live music for this year.

Merck KGaA, Darmstadt, Germany, a leading science and technology company, announced today that following Priority Review, the China National Medical Products Administration (NMPA) has approved pimicotinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause functional limitation or relatively severe morbidity. Pimicotinib, a colony stimulating factor-1 receptor (CSF-1R) inhibitor developed by Abbisko Therapeutics Co., Ltd., Shanghai, China, is the first Chemical Drug Class 1 approved in China for the treatment of TGCT.

Incyte Biosciences Japan G.K. today announced approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for Minjuvi® (tafasitamab) in combination with rituximab and lenalidomide for adult patients with relapsed or refractory follicular lymphoma (2L+ FL).

Incyte Biosciences Japan G.K. today announced the Japan Ministry of Health, Labour and Welfare (MHLW) approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of advanced squamous cell carcinoma of the anal canal (SCAC).

ENHERTU® (trastuzumab deruxtecan) has been granted Breakthrough Therapy Designation (BTD) in the U.S. for adult patients with HER2 positive early breast cancer with residual invasive disease in the breast and/or axillary lymph nodes after neoadjuvant treatment and high risk of disease recurrence.

The first patient has been dosed in the DESTINY-Endometrial02 phase 3 trial evaluating ENHERTU® (trastuzumab deruxtecan) with or without radiotherapy compared to standard of care chemotherapy with or without radiotherapy as an adjuvant treatment (after surgery) in patients with HER2 expressing (IHC 3+/2+) endometrial cancer.

JAB Insurance today announced that it has entered into a definitive agreement to acquire from Utmost Group plc its Life and Pensions business (“ULP”), a UK life and pensions platform with more than £5 billion of assets under management and serving approximately 290,000 pensioners.

Regulatory News:

Mitsubishi Electric Corporation (TOKYO: 6503) announced today that it has invested in and signed a strategic alliance agreement with Tulip Interfaces, Inc., a Massachusetts, USA-based leader no-code platforms for system operations without programming to support manufacturing digitalization. Tulip Interfaces is also an expert in introducing manufacturing-targeted microservices, which divide large-scale systems into small, independent services to enable flexible development and operations. Through this partnership, Mitsubishi Electric aims to build a no-code system-development platform to strengthen its digital-transformation (DX) solutions for manufacturing and other sectors.

Regulatory News:

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved CD20xCD3 bispecific Lunsumio VELO™ (mosunetuzumab-axgb), as a subcutaneous (SC) formulation, for the treatment of adult patients with relapsed or refractory (R/R) follicular lymphoma (FL) after two or more lines of systemic therapy, based on results from the Phase I/II GO29781 study. Based on the study results, Lunsumio VELO is approved under accelerated approval. Full approval for this regimen may be contingent on verification and confirmation of benefit in a confirmatory trial.

Regulatory News:

e.l.f. Cosmetics, a brand from e.l.f. Beauty (NYSE: ELF), the bold disruptor with a kind heart, today announced the extension of its partnership with The Wonder Women of Wrestling Foundation (WWOWF) for a second consecutive year. e.l.f. returns as the first-ever beauty sponsor of the WWOWF Varsity Girls Wrestling Tournament on December 29-30, 2025, in Columbia, Missouri.

QAD | Redzone, the company redefining manufacturing and supply chains through intelligent, adaptive solutions, today announced the winners of the 2025 QAD | Redzone India Champions of Change Awards at Champions of Manufacturing India in Mumbai.

Access Advance LLC, the global leader in video codec patent pool licensing, today announced that Hisense Group Holdings Co., Ltd. has joined the HEVC Advance Patent Pool as a Licensee. Hisense joins the recent additions to the Access Advance patent pools, including Xiaomi, MSI, Transsion, and expanded relationships with Huawei, HP and Sharp.

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Clearwater Analytics Holdings, Inc. (NYSE: CWAN) to Permira and Warburg Pincus for $24.55 per share in cash is fair to Clearwater shareholders.

Nidec Corporation (TOKYO: 6594; OTC US: NJDCY) (the “Company”) today announced the resignation of a Representative Director and member of the Board of Director of the Company, and a change in his title, as described below.

Textron Aviation Defense LLC, a Textron Inc. (NYSE:TXT) company, today announced that the company has finalized its first contract to deliver the Beechcraft T-6JP Texan II integrated training system to Japan’s Air Self-Defense Force (JASDF), in coordination with Kanematsu Corporation. The initial contract includes two Beechcraft T-6JP Texan II aircraft and instructor pilot and aircraft maintainer training materials. Deliveries of the first two aircraft are scheduled for 2029, with additional contracts anticipated.

Clearwater Analytics (NYSE: CWAN) (“CWAN” or the “Company”), announced that it has entered into a definitive agreement to be acquired in a transaction valued at approximately $8.4 billion by a Permira and Warburg Pincus-led Investor Group (the “Investor Group”), with participation from Temasek. The Investor Group has key support from Francisco Partners.

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Wildermuth Fund (“Wildermuth Fund” or the “Company”) (NASDAQ: WESFX).

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Synopsys, Inc. (“Synopsys” or the “Company”) (NASDAQ: SNPS).

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Alexandria Real Estate Equities, Inc. (“Alexandria” or the “Company”) (NYSE: ARE) and reminds investors of the January 26, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Sprouts Farmers Market, Inc. (“Sprouts” or the “Company”) (NASDAQ: SFM).

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against James Hardie Industries plc (“James Hardie” or the “Company”) (NYSE: JHX) and reminds investors of the December 23, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Telix Pharmaceuticals Limited (“Telix” or the “Company”) (NASDAQ: TLX).

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Tvardi Therapeutics, Inc. (“Tvardi” or the “Company”) (NASDAQ: TVRD).

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Blue Owl Capital Inc. (“Blue Owl” or the “Company”) (NYSE: OWL) and reminds investors of the February 2, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Gauzy Ltd. (“Gauzy” or the “Company”) (NASDAQ: GAUZ) and reminds investors of the February 6, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Inspire Medical Systems, Inc. (“Inspire Medical” or the “Company”) (NYSE: INSP) and reminds investors of the January 5, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Rezolute, Inc. (“Rezolute” or the “Company”) (NASDAQ: RZLT).

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Freeport-McMoran Inc. (“Freeport” or the “Company”) (NYSE: FCX) and reminds investors of the January 12, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Stride, Inc. (“Stride” or the “Company”) (NYSE: LRN).

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against DeFi Technologies Inc. (“DeFi Technologies” or the “Company”) (NASDAQ: DEFT) and reminds investors of the January 30, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against StubHub Holdings, Inc. (“StubHub” or the “Company”) (NYSE: STUB).

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Nidec Corporation (“Nidec” or the “Company”) (OTC: NJDCY).

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Firefly Aerospace Inc. (“Firefly” or the “Company”) (NASDAQ: FLY) and reminds investors of the January 12, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Bitdeer Technologies Group (“Bitdeer” or the “Company”) (NASDAQ: BTDR) and reminds investors of the February 2, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Primo Brands Corporation (“Primo Brands” or the “Company”) (NYSE: PRMB).

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Avantor, Inc. (“Avantor” or the “Company”) (NYSE: AVTR) and reminds investors of the December 29, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Fluor Corporation (NYSE: FLR) announced today that it has reached an agreement to divest its portion of its Zhuhai fabrication yard in China’s Guangdong province to Offshore Oil Engineering Co., Ltd. (COOEC). Fluor expects to receive $122 million (¥859 million yuan) in proceeds, based on current exchange rates, when the transaction is completed in the coming months.

Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until February 17, 2026 to file lead plaintiff applications in a securities class action lawsuit against Coupang, Inc. (NYSE: CPNG), if they purchased or otherwise acquired the Company’s securities between August 6, 2025 and December 16, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of California.

Today, Council for Citizens Against Government Waste (CCAGW) President Tom Schatz issued the following statement in response to the announcement of two proposed Center for Medicare and Medicaid Innovation (CMMI) models, “GLOBE” and “GUARD,” that seek to advance so-called ‘most favored nation’ (MFN) drug price controls:

East West Bancorp, Inc. (“East West” or the “Company”) (Nasdaq: EWBC), announced plans to host conference calls to review financial results on the following dates:

VanEck announced today the following 2025 annual distributions per share for its VanEck® equity exchange-traded funds.

A Minnesota jury awarded $65.5 million to a 37-year-old mother of three minor children after finding in her favor in a lawsuit against Johnson & Johnson, concluding that the company’s talc products exposed her to asbestos and contributed to her developing peritoneal mesothelioma, a cancer of the peritoneal lining in the stomach.

Southern California Edison (the “Company”) today announced the expiration and results for the previously announced cash tender offer to purchase any and all of the outstanding 5.45% Fixed-to-Floating Rate Trust Preference Securities (the “Trust Securities” and such offer, the “Offer”) issued by SCE Trust V, a Delaware statutory trust subsidiary of the Company (the “Trust”), plus Accrued Distributions (as defined below).

Edison International (NYSE: EIX) today announced the expiration and results for its previously announced cash tender offers to purchase any and all of its outstanding 5.00% Fixed-Rate Reset Cumulative Perpetual Preferred Stock, Series B (the “Series B Preferred Stock” and such offer, the “Series B Offer”) and 5.375% Fixed-Rate Reset Cumulative Perpetual Preferred Stock, Series A (the “Series A Preferred Stock” and, together with the Series B Preferred Stock, the “Securities” and such offer, the “Series A Offer” and, together with the Series B Offer, the “Offers” and each, an “Offer”), plus Accrued Dividends (as defined below).

U-Haul® is offering 30 days of free self-storage and U-Box® container use at 37 Company facilities across Oregon and southern Washington to aid residents affected by the flash floods and potential landslides.

Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN), a clinical-stage breakthrough pharmaceutical company committed to revolutionizing mental healthcare by developing innovative next-generation treatment options, today announced that it will voluntarily transfer its U.S. stock exchange listing to the Nasdaq Global Market (“Nasdaq”) from the NYSE American LLC (“NYSE American”). The Company expects that its common shares will cease trading on the NYSE American at market close on January 2, 2026 and commence trading on Nasdaq at market open on January 5, 2026.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Coupang, Inc. (“Coupang” or the “Company”) (NYSE:CPNG) securities during the period of August 6, 2025 through December 16, 2025, inclusive (“the Class Period”).

The Global Healthy Living Foundation (GHLF) reached record global podcast and YouTube participation in 2025 with more than 700,000 podcast listens (up 63%) and 2 million YouTube views (up 97%) compared with 2024.

KBRA assigns a long-term rating of AAA to the Dallas Independent School District, TX: Unlimited Tax School Building Bonds, Series 2026A; and Variable Rate Unlimited Tax School Building Bonds, Series 2026B. KBRA additionally affirms the long-term rating of AAA for the District's outstanding Unlimited Tax Bonds (PSF) and Unlimited Tax Bonds (Non-PSF). The Outlook for each obligation is Stable.

Seacoast Banking Corporation of Florida (“Seacoast” or the “Company”) (NASDAQ: SBCF) announced that on December 19, 2025, its Board of Directors (the “Board”) renewed the Company's share repurchase program, which was set to expire on December 31, 2025. Under the renewed repurchase program, which will expire on December 31, 2026, the Company may repurchase, from time to time, up to $150 million of its shares of common stock, an increase over the current repurchase program. This represents approximately 5% of the Company’s outstanding common stock.

Momentus Inc. (NASDAQ: MNTS) (“Momentus” or the “Company”), a U.S. commercial space company that offers satellite buses, transportation and other in-space infrastructure services, announced today the granting of inducement awards to four new employees under Momentus’ 2022 Inducement Equity Plan. In accordance with NASDAQ Listing Rule 5635(c)(4), the awards were approved by Momentus’ Compensation Committee and made as a material inducement to each employee’s entry into employment with the Company.

Patria Investments Limited (“Patria”) (NASDAQ: PAX), a global alternative asset manager, announced today the implementation of a new corporate structure designed to enhance its global operating model, drive operational excellence, and better support Patria’s strategic execution at scale. To lead this new structure, Patria is creating the role of Global Chief Operating Officer (“COO”) and is pleased to introduce Nikitas Psyllakis, as its new Global COO, reporting directly to Patria’s Chief Executive Officer (“CEO”), Alex Saigh. Nikitas joins Patria as a Partner and will oversee the following corporate functions: Finance, Funds, Technology, Legal & Compliance, Risk Management and Internal Audit. As part of this organizational evolution, the current leaders of these corporate functions will now report directly to the new COO. Joining from DWS Group, Nikitas brings over 20 years of extensive global experience in financial services, having led strategic planning, operational transformation, and regulatory initiatives. His leadership will be instrumental in driving organizational effectiveness and supporting Patria’s evolving business needs. He will be based in London and serve as a member of the Management Committee.

Rithm Property Trust Inc. (NYSE: RPT, “RPT” or the “Company”) today announced that its Board of Directors unanimously approved a one-for-six reverse stock split (the “Reverse Stock Split”) of the Company’s issued and outstanding shares of common stock (the “Common Stock”).

State Street Corporation (NYSE: STT) plans to announce its fourth-quarter and full-year 2025 financial results on Friday, January 16, 2026 at approximately 7:30 a.m. ET. A conference call to review the firm’s financial results will be held at 11:00 a.m. ET.

Perfect Corp., the leader in AI and AR solutions for beauty, fashion, and retail, will reveal a new era of AI agents and developer-first API innovation at CES 2026. These advancements showcase how intelligent AI agents and modular, scalable APIs are redefining personalization, product discovery, and visual experiences for the modern shopper.

Virtus Equity & Convertible Income Fund (NYSE: NIE) today announced the following special year-end distribution to holders of its common shares.:

Virtus Artificial Intelligence & Technology Opportunities Fund (NYSE: AIO) today announced the following special year-end distribution to holders of its common shares:

UL Solutions Inc. (NYSE: ULS) (“UL Solutions”) today announced, in connection with its previously announced secondary public offering of 12,500,000 shares of its Class A common stock sold by UL Standards & Engagement (the “selling stockholder”), the full exercise by the underwriters of their option to purchase 1,875,000 additional shares of Class A common stock from the selling stockholder at the public offering price of $78.00 per share, less underwriting discounts and commissions. UL Solutions did not offer any shares of its Class A common stock in the offering and did not receive any proceeds from the sale of the additional shares. The sale of these additional shares closed today.

American Express Company (NYSE: AXP) plans to host live audio webcasts of its earnings conference calls to discuss the company’s quarterly financial results on the following dates:

KKR today announced income from monetization activity in excess of $525 million with respect to the period from October 1, 2025 through December 19, 2025 based on information available as of today. The quarter-to-date monetization activity is made up of approximately 95% realized performance income and approximately 5% realized investment income. Approximately 45% of realized performance income is driven by revenues from our strategic hedge fund partnerships that correspond to a 10-20% compensation rate.

Virtus Diversified Income & Convertible Fund (NYSE: ACV) today announced the following special year-end distribution to holders of its common shares:

Polestar (Nasdaq: PSNY) today announced a USD 300 million equity investment by Banco Bilbao Vizcaya Argentaria, S.A. and NATIXIS, with USD 150 million each. Concurrent with the purchase, these financial institutions have each entered into a put option arrangement with a wholly-owned subsidiary of Geely Sweden Holdings AB, which provides the financial institutions with an exit path, if needed, in three years with certain returns, as part of this equity financing arrangement.

Acadia Realty Trust (NYSE:AKR) (“Acadia” or the “Company”) today announced that David Buell will join the Company in January 2026 as its new Chief Accounting Officer succeeding Richard Hartmann.

Permianville Royalty Trust (NYSE: PVL, the “Trust”) today announced a cash distribution to the holders of its units of beneficial interest of $0.023000 per unit, payable on January 15, 2026 to unitholders of record on December 31, 2025. The net profits interest calculation represents reported oil production for the month of September 2025 and reported natural gas production during August 2025. The calculation includes accrued costs incurred in October 2025.

Mesa Royalty Trust (the “Trust”) (NYSE symbol-MTR) announced today the Trust income distribution for the month of December 2025. Unitholders of record on December 31, 2025 will receive distributions amounting to $0.018551844 per unit, payable on January 30, 2026. The Trust received $35,596, all of which came from the New Mexico portion of the Trust’s San Juan Basin properties operated by Hilcorp San Juan LP, an affiliate of Hilcorp Energy Company. No income was received in December 2025 from any other working interest owner. This month, after the Trust’s payment of administrative expenses, income from the distributable net profits was $34,573.

Aravolta is redefining data center operations for colocations, clouds, edge data centers, universities and more. Aravolta builds integrated data center infrastructure (DCIM), electrical power (EPMS) and building management (BMS) products and are rapidly expanding as demand soars for their products.

Comfort Systems USA, Inc. (NYSE: FIX) (the “Company”), a leading provider of commercial, industrial and institutional heating, ventilation, air conditioning and electrical contracting services, today announced that Trent T. McKenna, currently Executive Vice President and Chief Operating Officer, will be appointed to serve as President and Chief Operating Officer, effective January 1, 2026. Brian E. Lane will continue to serve as Chief Executive Officer of the Company.

The Foundation for the National Institutes of Health (FNIH) announces that the Food and Drug Administration (FDA) has qualified the treatment-related change in hip bone mineral density (BMD) as a surrogate endpoint for bone fractures in clinical trials of anti-osteoporosis drugs in post-menopausal women at risk for osteoporotic fracture.

On Thursday, January 22, 2026, at approximately 4:05 p.m. Eastern Time, Capital One Financial Corporation (NYSE: COF) will release its fourth quarter 2025 earnings results. Additionally, the company will host a conference call at 5:00 p.m. Eastern Time to review financial and operating performance for the quarter ending December 31, 2025.

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced that the Compensation Committee of its Board of Directors has granted equity awards to two new employees as equity inducement awards outside of the Company's 2017 Equity Incentive Plan, but under the terms of the 2017 Inducement Equity Incentive Plan. The equity awards were approved and issued on December 15, 2025, in accordance with Nasdaq Listing Rule 5635(c)(4).